Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
WuXi Biologics (Cayman) Inc
F:1FW1
WuXi Biologics (Cayman) Inc
F:1FW1
Price:
12.4
EUR
5.08%
Market Closed
Market Cap:
€25.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
WuXi Biologics (Cayman) Inc
F:1FW1
|
CN |
|
N
|
Northern Trust Corp
F:NT4
|
US |
|
Tertiary Minerals PLC
LSE:TYM
|
UK |
|
J
|
Jardine Cycle & Carriage Ltd
XMUN:CYC
|
SG |
Wall St Price Targets
1FW1 Price Forecast
Based on 23 analysts
Based on 23 analysts
+9% Upside
from
€12.4
today
WuXi Biologics (Cayman) Inc (1FW1)’s 12-month stock price forecast through September 2027 has a consensus target of €13.54, implying 9% upside. The forecast is based on price targets from 23 Wall Street analysts.
1FW1 Analyst Rating
No ratings yet
No ratings yet
WuXi Biologics (Cayman) Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1FW1's stock price target?
Price Target
13.54
EUR
13.54
EUR
According to Wall Street analysts, the average 1-year price target for 1FW1 is 13.54 EUR with a low forecast of 8 EUR and a high forecast of 18.06 EUR.
What is the Revenue forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
11%
Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
11%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 49%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
15%
15%
Over the last 10 years, the compound annual growth rate for Operating Income has been 60%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
21%
21%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 60%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
13%
13%
Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 13%.